the aid library

LIST OPTIONS

Filter

1502

Sort by:

Direction:

Download (2211)

View PDF (3342)

For Proper Disposal Hospital Waste

Jorge Emmanuel and Ruth Stringer Health Care Without Harm (2007)

A Global Inventory of Alternative Medical Waste Treatment Technologies

Download (1549)

View PDF (1507)

Outil d’évaluation de la lutte contre les infections

USAID; Managment of Health Sciences MSH (2009) C1

2e edition

Download (1917)

View PDF (4058)

Polio Laboratory Manual

World Health Organization (2004) C_WHO

Download (1005)

View PDF (1916)

Training Manual for SODIS Promotion

SODIS Solar Water Disinfection SODIS Solar Water Disinfection (2006)

Download (327)

View PDF (474)

WHO Recommended Surveillance Standards Meningococcal disease

World Health Organization (2000)

Download (176)

View PDF (803)

Out of the dark: Meeting the needs of children with TB

Médecins sans Frontières (2011) C3

Download (174)

View PDF (1280)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis

M. E. Balcells, S. L. Thomas, P. Godfrey-Faussett, et al. (2006) C_CDC

Research Emerging Infectious Diseases Vol. 12, No. 5, May 2006

Download (1433)

View PDF (1940)

Herramienta de Evaluación del Control de Infecciones

USAID; Managment of Health Sciences MSH (2007) C1

Download (399)

View PDF (746)

Guidelines on Drug Registration Applications in Botswana

Drugs Advisory Board, Republic of Botswana (Gabarone, Botswana) (2000)

First Revised Edition March 2000

Download (308)

View PDF (1159)

Cholera Surveillance: Detecting and Reporting Cases

Johns Hopkins Bloomberg School of Public Health (2015) C1

The intention of this document is to clarify and outline the steps to effective cholera surveillance. It discusses when, where and why surveillance for cholera is needed and how to establish a useful and cost-effective surveillance system for cholera. To make comments, corrections and additions,... more

Download (1134)

View PDF (3828)

Guide to good storage practices for pharmaceuticals (GSP)
recommended

World Health Organization WHO (2003) C_WHO

WHO Technical Report Series, No. 908, 2003, Annex 9. This guide is intended for those involved in the storage, transportation and distribution of pharmaceuticals. It describes the special measures considered appropriate for the storage and transportation of pharmaceuticals.

Download (2042)

View PDF (1110)

Glossary of terms used in Pharmacovigilance

World Health Organization (WHO) (2011) C_WHO

Download (315)

View PDF (419)

Ghidul pentru diagnosticul si tratamentul tuberculozei la copii

Prof. Dr. I. P. Stoicescu, Dr. Marilena C., Dr. A. Macri, et al. Institutul National de Cercetare-Dezvoltare in Sanatate Bucuresti (2006) C2

Download (135)

View PDF (135)

Programme nutritionnel supplémentaire au Sénégal

Roullaud, S. Université Henri Poncare, Nancy, Faculté de médécine de Nancy (2001) C2

Après un rappel des données générales sur la malnutrition infantile, nous décrirons l'évolution de la mortalité et de la morbidité de ce fléau. Puis, nous exposerons la méthodologie et les résultats de notre étude. L'étude est d'abord rétrospective, analysant les indicateurs de fonctio... more

Download (78)

View PDF (644)

Reducing Antimicrobial Resistance and Hospital-Associated Infections: The Role of the Hospitalist

Dressler D. D., MD, MSc Director OF Society of Hospital Medicine (2005) CC

While infections that develop during hospitalization may appear to be an uncommon but recognized risk of hospital care today, the incidence of these infections has been increasing dramatically during the last 2 to 3 decades, and the risk of acquiring an organism that is resistant to 1 or more antibi... more

Download (269)

View PDF (204)

ASHP Guidelines on Pharmacy-Prepared Ophthalmic Products

American Society of Hospital Pharmacists (ASHP) ASHP (2008) CC

Drug Distribution and Control: Preparation and Handling–Guidelines Review 2008

Download (181)

View PDF (133)

Manual del Vacunador Vacuna MODERNA

Dirección de Control de Enfermedades Inmunoprevenibles Ministerio de Salud Argentina (2021) CC

Vaccinator's Manual. MODERNA Vaccine

Download (13)

View PDF (11)

List of key WHO-recommended maternal and newborn health commodities

World Health Organisation (WHO) (2024) C_WHO

This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.

Download (6)

View PDF (5)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (3)

View PDF (5)

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren... more

Guide to good storage practices for pharmaceuticals (GSP) recommended

Guide to good storage practices for pharmaceuticals (GSP)
recommended